Abiomed (NASDAQ:ABMD) reported its Q3 earnings results on Thursday, February 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Abiomed beat estimated earnings by 16.49%, reporting an EPS of $1.13 versus an estimate of $0.97, which surprised analysts.
Revenue was up $29.51 million from the same period last year.
Also check out this: Insiders Buying Charter Communications And 3 More Stocks
Past Earnings Performance
Last quarter the company beat on EPS by $0.06, which was followed by a 3.23% drop in the share price the next day.
Here's a look at Abiomed's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.97 | 1.05 | 1.10 | 1.13 |
| EPS Actual | 1.03 | 1.10 | 1.24 | 1.35 |
| Revenue Estimate | 247.66M | 240.91M | 230.38M | 225.59M |
| Revenue Actual | 248.14M | 252.59M | 241.25M | 231.66M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
